ObsEva SA to Hold First Quarter 2017 Financial Results and Business Update Call on Thursday, May 18, 2017

Thursday, May 11, 2017 11:02 AM UTC

Geneva, Switzerland and Boston, MA - May 11, 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, today announced that it will report financial results for the first quarter ended March 31, 2017 on Thursday, May 18, 2017. ObsEva will host an investment community conference call at 8:00 a.m. Eastern Time (2:00 p.m. Central European Time) on May 18, 2017 to discuss the financial results and provide a corporate update.

Investors may participate in the conference call by dialing 844-419-1772 for U.S. callers and (213) 660-0921 for international callers, with conference ID: 21002537.

Those interested in listening to the conference call live via the internet may do so by visiting the "Investors" page of ObsEva's website at www.obseva.com and clicking on the webcast link.

A webcast replay of the conference call will be available on the "Investors" page of ObsEva's website at www.obseva.com.

About ObsEva

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV". For more information, please visit www.ObsEva.com.

###

Media Contact:

Liz Bryan
Spectrum Science
[email protected]
202-955-6222 x2526

Investor Contact:

Mario Corso
Senior Director, Investor Relations
[email protected]
781-366-5726

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/0f853e1e-9419-4a3b-85af-60e6f96631b6

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

ObsEva SA to Hold First Quarter 2017 Financial Results and Business Update Call on Thursday, May 18, 2017

Editor's Picks

Welcome to EconoTimes